Dysplasie ventriculaire droite arythmogène

Translated title of the contribution: Arrhythmogenic right ventricular dysplasia

A. Leenhardt, P. Milliez, A. Haggui, Seiji Takatsuki, M. Hayashi, M. Meddane, P. Dejode, I. Denjoy, F. Extramiana

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Arrhythmogenic right ventricular dysplasia (ARVD) is a cardiomyopathy of the right ventricle due to adipose infiltration of the myocardium with surviving myocardial fibres surrounded by fibrosis. It gives rise to right ventricular dilatation, which starts locally before becoming diffuse, and, sometimes in the late stages, to symptoms of cardiac failure. It may also be associated with left ventricular involvement. The main complication is sudden death due to a ventricular arrhythmia. ARVD is responsible for 3 to 10% of all unexplained sudden deaths before 65 years of age. ARVD has a genetic origin, with some recessive but a majority of autosomal dominant forms. Nine different loci have been reported in the autosomal dominant forms and four genes have been identified. A number of these mutations is responsible for abnormalities of cellular junction, more specifically of the desmosomes. These studies have shown several different forms of ARVD and, consequently, the term arrhythmogenic right ventricular cardiomyopathy would be a more appropriate terminology for the pathology. This paper reviews the diagnostic, genetic and therapeutic aspects of the disease. In particular, the evaluation of the arrhythmic risk is underlined as it is an important and difficult problem which has not yet been satisfactorily resolved. It requires integration of clinical and electrocardiographic criteria with morphological and functional imaging methods. Molecular biology could play a role in the prognostic assessment in the future.

Original languageFrench
Pages (from-to)7-14
Number of pages8
JournalArchives des Maladies du Coeur et des Vaisseaux
Volume99
Issue numberSPEC. ISS. 5
Publication statusPublished - 2006 Dec
Externally publishedYes

Fingerprint

Arrhythmogenic Right Ventricular Dysplasia
Sudden Death
Desmosomes
Cardiomyopathies
Terminology
Heart Ventricles
Cardiac Arrhythmias
Molecular Biology
Dilatation
Myocardium
Fibrosis
Heart Failure
Pathology
Mutation
Genes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Leenhardt, A., Milliez, P., Haggui, A., Takatsuki, S., Hayashi, M., Meddane, M., ... Extramiana, F. (2006). Dysplasie ventriculaire droite arythmogène. Archives des Maladies du Coeur et des Vaisseaux, 99(SPEC. ISS. 5), 7-14.

Dysplasie ventriculaire droite arythmogène. / Leenhardt, A.; Milliez, P.; Haggui, A.; Takatsuki, Seiji; Hayashi, M.; Meddane, M.; Dejode, P.; Denjoy, I.; Extramiana, F.

In: Archives des Maladies du Coeur et des Vaisseaux, Vol. 99, No. SPEC. ISS. 5, 12.2006, p. 7-14.

Research output: Contribution to journalArticle

Leenhardt, A, Milliez, P, Haggui, A, Takatsuki, S, Hayashi, M, Meddane, M, Dejode, P, Denjoy, I & Extramiana, F 2006, 'Dysplasie ventriculaire droite arythmogène', Archives des Maladies du Coeur et des Vaisseaux, vol. 99, no. SPEC. ISS. 5, pp. 7-14.
Leenhardt A, Milliez P, Haggui A, Takatsuki S, Hayashi M, Meddane M et al. Dysplasie ventriculaire droite arythmogène. Archives des Maladies du Coeur et des Vaisseaux. 2006 Dec;99(SPEC. ISS. 5):7-14.
Leenhardt, A. ; Milliez, P. ; Haggui, A. ; Takatsuki, Seiji ; Hayashi, M. ; Meddane, M. ; Dejode, P. ; Denjoy, I. ; Extramiana, F. / Dysplasie ventriculaire droite arythmogène. In: Archives des Maladies du Coeur et des Vaisseaux. 2006 ; Vol. 99, No. SPEC. ISS. 5. pp. 7-14.
@article{601c400838ab47919d6c11ed69eb6f2d,
title = "Dysplasie ventriculaire droite arythmog{\`e}ne",
abstract = "Arrhythmogenic right ventricular dysplasia (ARVD) is a cardiomyopathy of the right ventricle due to adipose infiltration of the myocardium with surviving myocardial fibres surrounded by fibrosis. It gives rise to right ventricular dilatation, which starts locally before becoming diffuse, and, sometimes in the late stages, to symptoms of cardiac failure. It may also be associated with left ventricular involvement. The main complication is sudden death due to a ventricular arrhythmia. ARVD is responsible for 3 to 10{\%} of all unexplained sudden deaths before 65 years of age. ARVD has a genetic origin, with some recessive but a majority of autosomal dominant forms. Nine different loci have been reported in the autosomal dominant forms and four genes have been identified. A number of these mutations is responsible for abnormalities of cellular junction, more specifically of the desmosomes. These studies have shown several different forms of ARVD and, consequently, the term arrhythmogenic right ventricular cardiomyopathy would be a more appropriate terminology for the pathology. This paper reviews the diagnostic, genetic and therapeutic aspects of the disease. In particular, the evaluation of the arrhythmic risk is underlined as it is an important and difficult problem which has not yet been satisfactorily resolved. It requires integration of clinical and electrocardiographic criteria with morphological and functional imaging methods. Molecular biology could play a role in the prognostic assessment in the future.",
author = "A. Leenhardt and P. Milliez and A. Haggui and Seiji Takatsuki and M. Hayashi and M. Meddane and P. Dejode and I. Denjoy and F. Extramiana",
year = "2006",
month = "12",
language = "French",
volume = "99",
pages = "7--14",
journal = "Archives of Cardiovascular Diseases",
issn = "1875-2136",
publisher = "Elsevier Masson",
number = "SPEC. ISS. 5",

}

TY - JOUR

T1 - Dysplasie ventriculaire droite arythmogène

AU - Leenhardt, A.

AU - Milliez, P.

AU - Haggui, A.

AU - Takatsuki, Seiji

AU - Hayashi, M.

AU - Meddane, M.

AU - Dejode, P.

AU - Denjoy, I.

AU - Extramiana, F.

PY - 2006/12

Y1 - 2006/12

N2 - Arrhythmogenic right ventricular dysplasia (ARVD) is a cardiomyopathy of the right ventricle due to adipose infiltration of the myocardium with surviving myocardial fibres surrounded by fibrosis. It gives rise to right ventricular dilatation, which starts locally before becoming diffuse, and, sometimes in the late stages, to symptoms of cardiac failure. It may also be associated with left ventricular involvement. The main complication is sudden death due to a ventricular arrhythmia. ARVD is responsible for 3 to 10% of all unexplained sudden deaths before 65 years of age. ARVD has a genetic origin, with some recessive but a majority of autosomal dominant forms. Nine different loci have been reported in the autosomal dominant forms and four genes have been identified. A number of these mutations is responsible for abnormalities of cellular junction, more specifically of the desmosomes. These studies have shown several different forms of ARVD and, consequently, the term arrhythmogenic right ventricular cardiomyopathy would be a more appropriate terminology for the pathology. This paper reviews the diagnostic, genetic and therapeutic aspects of the disease. In particular, the evaluation of the arrhythmic risk is underlined as it is an important and difficult problem which has not yet been satisfactorily resolved. It requires integration of clinical and electrocardiographic criteria with morphological and functional imaging methods. Molecular biology could play a role in the prognostic assessment in the future.

AB - Arrhythmogenic right ventricular dysplasia (ARVD) is a cardiomyopathy of the right ventricle due to adipose infiltration of the myocardium with surviving myocardial fibres surrounded by fibrosis. It gives rise to right ventricular dilatation, which starts locally before becoming diffuse, and, sometimes in the late stages, to symptoms of cardiac failure. It may also be associated with left ventricular involvement. The main complication is sudden death due to a ventricular arrhythmia. ARVD is responsible for 3 to 10% of all unexplained sudden deaths before 65 years of age. ARVD has a genetic origin, with some recessive but a majority of autosomal dominant forms. Nine different loci have been reported in the autosomal dominant forms and four genes have been identified. A number of these mutations is responsible for abnormalities of cellular junction, more specifically of the desmosomes. These studies have shown several different forms of ARVD and, consequently, the term arrhythmogenic right ventricular cardiomyopathy would be a more appropriate terminology for the pathology. This paper reviews the diagnostic, genetic and therapeutic aspects of the disease. In particular, the evaluation of the arrhythmic risk is underlined as it is an important and difficult problem which has not yet been satisfactorily resolved. It requires integration of clinical and electrocardiographic criteria with morphological and functional imaging methods. Molecular biology could play a role in the prognostic assessment in the future.

UR - http://www.scopus.com/inward/record.url?scp=33846882144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846882144&partnerID=8YFLogxK

M3 - Article

VL - 99

SP - 7

EP - 14

JO - Archives of Cardiovascular Diseases

JF - Archives of Cardiovascular Diseases

SN - 1875-2136

IS - SPEC. ISS. 5

ER -